SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

10359	Companies
215666	Keywords
145448	Articles
114230	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 02/17/2026 at 12:00, 2 months 17 days ago

Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
Sanofi and Teva's duvakitug phase 2b maintenance data show durable efficacy in ulcerative colitis and Crohn's disease. Results reinforce ongoing phase 3 programs in UC and CD

Ulcerative Colitis Sanofi Teva Crohn's Disease Duvakitug
BRIEF

published on 02/16/2026 at 07:05, 2 months 19 days ago

Beyfortus Shows Extended Benefits for Infants Against RSV

Infant Health Beyfortus Hospitalization Reduction RSV Immunization NIRSE-GAL Study
BRIEF

published on 02/16/2026 at 07:05, 2 months 19 days ago

Beyfortus prouve son efficacité au-delà de la première saison du VRS

Sanofi VRS Beyfortus Nourrissons Immunisation
BRIEF

published on 02/16/2026 at 07:05, 2 months 19 days ago

Beyfortus proves its effectiveness beyond the first season of VRS

Sanofi VRS Beyfortus Infants Immunization
BRIEF

published on 02/16/2026 at 07:05, 2 months 19 days ago

Beyfortus présente des bénéfices prolongés chez les nourrissons contre le VRS

Beyfortus Réduction Des Hospitalisations Santé Infantile Vaccination Contre Le VRS Étude NIRSE-GAL
PRESS RELEASE

published on 02/16/2026 at 07:00, 2 months 19 days ago

Communiqué de presse : L’étude sur Beyfortus publiée dans la revue The Lancet Infectious Diseases montre ses bénéfices chez les nourrissons au-delà de la première saison du VRS
Étude sur Beyfortus montrant réduction significative des hospitalisations liées au VRS chez les nourrissons. Résultats présentés dans The Lancet Infectious Diseases et à la conférence 2026 de la Semaine du vaccin contre le VRS

VRS Étude Beyfortus Nourrissons Hospitalisations
PRESS RELEASE

published on 02/16/2026 at 07:00, 2 months 19 days ago

Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season
Universal RSV immunization with Beyfortus reduces hospitalizations in infants across two seasons, as per study in The Lancet Infectious Diseases and RSVVW '26 conference findings

RSV Beyfortus Infants Immunization Hospitalizations
BRIEF

published on 02/10/2026 at 15:05, 2 months 24 days ago

Sanofi finalise l'acquisition de Dynavax

Acquisition Biopharma Sanofi Vaccins Dynavax
BRIEF

published on 02/10/2026 at 15:05, 2 months 24 days ago

Sanofi Finalizes Acquisition of Dynavax

Acquisition Biopharma Sanofi Vaccines Dynavax
PRESS RELEASE

published on 02/10/2026 at 15:00, 2 months 24 days ago

Press Release: Sanofi completes the acquisition of Dynavax
Sanofi completes acquisition of Dynavax, bolstering presence in adult immunization with HEPLISAV-B vaccine and Z-1018 shingles vaccine candidate, enhancing global reach and development capabilities

Acquisition Sanofi Vaccine Immunization Dynavax

Accesswire

Published on 05/07/2026 at 05:40, 3 hours 23 minutes ago

New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 7 hours 3 minutes ago

Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 9 hours 33 minutes ago

Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 9 hours 58 minutes ago

Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 10 hours 3 minutes ago

Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 08:48, 15 minutes ago

Finnvera’s Annual General Meeting: New members to Finnvera’s Board of Directors and Supervisory Board
Published on 05/07/2026 at 08:36, 27 minutes ago

Cherry SE publishes results for the first quarter of 2026 – Operating profitability significantly improved
Published on 05/07/2026 at 08:30, 32 minutes ago

15 Years Delivering to You
Published on 05/07/2026 at 08:30, 32 minutes ago

L'UE mise sur une politique climatique axée sur le marché: allègement des péages et des normes CO₂ pour les poids lourds
Published on 05/07/2026 at 08:30, 33 minutes ago

Restoration: Grand Vision Media Holdings PLC

Les Echos

Published on 05/07/2026 at 07:43, 1 hour 19 minutes ago

ENGIE - Q1 2026 financial information
Published on 05/07/2026 at 07:43, 1 hour 19 minutes ago

ENGIE - Information Financière 1er trimestre 2026
Published on 05/06/2026 at 18:00, 15 hours 3 minutes ago

Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 15 hours 3 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 15 hours 3 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026

View all LES ECHOS COMFI WIRE